Rabbit hole 01
GLP‑1s
The full 3 part series, sourced and in plain English. Want it in your inbox instead? Sign up here.
Part 1 of 3
it's not an appetite suppressant (not the way you think)
You picked GLP-1s. Here's the straight dose.
GLP-1 is a hormone your own gut releases after you eat. The medicines in this class are built to act on the same receptor and last longer.
They work in three places at once: they slow how fast your stomach empties, they signal the brain's appetite centers, and they help release insulin only when blood sugar is up. That last part is why they rarely cause low blood sugar on their own.
That's very different from old school stimulant diet pills. It also explains the common side effects: the same slowdown that makes you full sooner can upset your stomach early on.
Who they're for is a prescriber's call, made with your history and labs.
Sources: NIH review on GLP-1 and gastric function · Incretin agonists review
Part 2 of 3
5 questions to ask before starting a GLP-1
Last time: how GLP-1 medicines work. Today: the questions worth asking before anyone starts one.
1. Any thyroid cancer in my family? The FDA label carries a boxed warning: these medicines caused thyroid C-cell tumors in rodents, and they're not for anyone with a personal or family history of medullary thyroid cancer or MEN 2.
2. Ever had pancreatitis or gallbladder trouble? Both are listed warnings on the label.
3. Planning a pregnancy? The label says to stop at least 2 months before a planned pregnancy, because the drug stays in your system a long time.
4. What's the plan if I stop? In the STEP 1 trial, people who stopped semaglutide regained about two thirds of the weight they'd lost within a year.
5. How do I keep my muscle? That's the next email.
A good prescriber walks through all five with you. If nobody asks, you ask.
Sources: FDA Wegovy prescribing information (2026) · STEP 1 extension, weight regain after stopping
Part 3 of 3
losing weight shouldn't mean losing muscle
Here's the part of the GLP-1 story that doesn't make the ads.
When trials scanned people's bodies, a real share of the weight lost wasn't fat. A 2026 meta-analysis found lean mass made up roughly 25 to 39 percent of the weight lost on these medicines. Lean mass includes water and organs, not just muscle, but muscle is part of it.
Why it matters: muscle helps you stay strong, keep your metabolism up, and keep the weight off.
What helps, per a 2025 joint advisory from four obesity and nutrition groups and a 2025 review: lift (structured resistance training a few times a week), and eat enough protein, above 1.2 grams per kilogram of body weight a day, spread across meals.
Small appetite + low protein + no lifting is the combo to avoid.
Want more? Reply and tell us what you want covered next.
Sources: Lean mass meta-analysis, Diabetes Obes Metab 2026 · Joint advisory on nutrition with GLP-1s, AJCN 2025 · Optimizing GLP-1 therapies, Obesity Pillars 2025
Send me the next topic